A randomized controlled trial of the efficacy and safety of twice-daily saxagliptin plus metformin combination therapy in patients with type 2 diabetes and inadequate glycemic control on metformin monotherapy

Glycemic Control ◽

Combination Therapy ◽

Controlled Trial ◽

Efficacy And Safety ◽

Randomized Controlled ◽

Metformin Monotherapy ◽

Inadequate Glycemic Control

Withdrawal of sulfonylureas from patients with type 2 diabetes receiving long-term sulfonylurea and insulin combination therapy results in deterioration of glycemic control: a randomized controlled trial

Diabetes Metabolic Syndrome and Obesity Targets and Therapy ◽

10.2147/dmso.s78008 ◽

2015 ◽

pp. 137 ◽

Cited By ~ 5

Author(s):

Weerachai Srivanichakorn ◽

Nuntakorn Thongtang ◽

Apiradee Sriwijitkamol ◽

Aroon Kongchoo ◽

Sutin Sriussadaporn ◽

...

Keyword(s):

Type 2 Diabetes ◽

Glycemic Control ◽

Combination Therapy ◽

Controlled Trial ◽

Efficacy and safety of initial combination therapy with gemigliptin and metformin compared with monotherapy with either drug in patients with type 2 diabetes: A double-blind randomized controlled trial (INICOM study)

Diabetes Obesity and Metabolism ◽

10.1111/dom.12787 ◽

2016 ◽

Vol 19 (1) ◽

pp. 87-97 ◽

Cited By ~ 6

Author(s):

Soo Lim ◽

Kyung Ah Han ◽

JaeMyung Yu ◽

Parinya Chamnan ◽

Eun Sook Kim ◽

...

Keyword(s):

Type 2 Diabetes ◽

Combination Therapy ◽

Controlled Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Randomized Controlled ◽

Initial Combination Therapy ◽

Initial Combination

Inhaled Insulin Improves Glycemic Control When Substituted for or Added to Oral Combination Therapy in Type 2 Diabetes: A Randomized Controlled Trial

Yearbook of Endocrinology ◽

10.1016/s0084-3741(08)70286-5 ◽

2006 ◽

Vol 2006 ◽

pp. 61-65

Author(s):

J.L. Leahy

Keyword(s):

Type 2 Diabetes ◽

Glycemic Control ◽

Combination Therapy ◽

Controlled Trial ◽

Inhaled Insulin ◽

Intervention of the Flash Glucose Sensing Technology on Glycemic Control and Treatment Satisfaction in Patients with Type 2 Diabetes Treated Intensively by Insulin—A Randomized Controlled Trial

Diabetes ◽

10.2337/db18-908-p ◽

2018 ◽

Vol 67 (Supplement 1) ◽

pp. 908-P ◽

Cited By ~ 1

Author(s):

MARIANNA YARON ◽

EYTAN ROITMAN ◽

GENYA AHARON-HANANEL ◽

ZOHAR LANDAU ◽

TALI GANZ ◽

...

Keyword(s):

Type 2 Diabetes ◽

Glycemic Control ◽

Treatment Satisfaction ◽

Controlled Trial ◽

Glucose Sensing ◽

Randomized Controlled ◽

Sensing Technology

110-LB: The Korean Titration: A Randomized Controlled Trial to Evaluate the Efficacy and Safety of Self-Titration Algorithms of Insulin Glargine 300 Units/ml in Patients with Uncontrolled Type 2 Diabetes

Diabetes ◽

10.2337/db20-110-lb ◽

2020 ◽

Vol 69 (Supplement 1) ◽

pp. 110-LB

Author(s):

JAE HYUN BAE ◽

CHANG HO AHN ◽

YE SEUL YANG ◽

SUN JOON MOON ◽

SOO HEON KWAK ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Controlled Trial ◽

Efficacy And Safety ◽

88-LB: Similar Efficacy and Safety of IGlarLixi When Initiated in Patients with Type 2 Diabetes (T2D) with or without Concomitant Sodium-Glucose Cotransporter-2 Inhibitor (SGLT2i) Use in a Randomized Controlled Trial (RCT) and Real-World Setting

Diabetes ◽

10.2337/db20-88-lb ◽

2020 ◽

Vol 69 (Supplement 1) ◽

pp. 88-LB

Author(s):

JULIO ROSENSTOCK ◽

AMAR ALI ◽

JURIS J. MEIER ◽

FRANCESCO GIORGINO ◽

CRISTIAN GUJA ◽

...

Keyword(s):

Type 2 Diabetes ◽

Real World ◽

Controlled Trial ◽

Similar Efficacy ◽

Efficacy And Safety ◽

Randomized Controlled ◽

Real World Setting ◽

Sodium Glucose Cotransporter

A Randomized, Placebo‐controlled Trial to Assess the Efficacy and Safety of Sitagliptin in Japanese Patients with Type 2 Diabetes and Inadequate Glycemic Control on Ipragliflozin

Diabetes Obesity and Metabolism ◽

10.1111/dom.14346 ◽

2021 ◽

Author(s):

Yutaka Seino ◽

Kohei Kaku ◽

Takashi Kadowaki ◽

Taro Okamoto ◽

Asako Sato ◽

...

Keyword(s):

Type 2 Diabetes ◽

Glycemic Control ◽

Controlled Trial ◽

Japanese Patients ◽

Efficacy And Safety ◽

Inadequate Glycemic Control

Efficacy and Safety of Switching from Low-Dose Statin to High-Intensity Statin for Primary Prevention in Type 2 Diabetes: A Randomized Controlled Trial

Diabetes Metabolic Syndrome and Obesity Targets and Therapy ◽

10.2147/dmso.s219496 ◽

2020 ◽

Vol Volume 13 ◽

pp. 423-431 ◽

Cited By ~ 1

Author(s):

Nuntakorn Thongtang ◽

Jirasak Piyapromdee ◽

Natthakan Tangkittikasem ◽

Kittichai Samaithongcharoen ◽

Nithiwat Srikanchanawat ◽

...

Keyword(s):

Type 2 Diabetes ◽

Primary Prevention ◽

High Intensity ◽

Low Dose ◽

Controlled Trial ◽

Efficacy And Safety ◽

Efficacy and Safety of Dulaglutide Monotherapy Versus Metformin in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-3)

Diabetes Care ◽

10.2337/dc13-2759 ◽

2014 ◽

Vol 37 (8) ◽

pp. 2168-2176 ◽

Cited By ~ 166

Author(s):

Guillermo Umpierrez ◽

Santiago Tofé Povedano ◽

Federico Pérez Manghi ◽

Linda Shurzinske ◽

Valeria Pechtner

Keyword(s):

Type 2 Diabetes ◽

Controlled Trial ◽

Efficacy And Safety ◽

Effects of Dapagliflozin on 24-Hour Glycemic Control in Patients with Type 2 Diabetes: A Randomized Controlled Trial

Diabetes Technology & Therapeutics ◽

10.1089/dia.2018.0052 ◽

2018 ◽

Vol 20 (11) ◽

pp. 715-724 ◽

Cited By ~ 19

Author(s):

Robert R. Henry ◽

Poul Strange ◽

Rong Zhou ◽

Jeremy Pettus ◽

Leon Shi ◽

...

Keyword(s):

Type 2 Diabetes ◽

Glycemic Control ◽

Controlled Trial ◽